Lucid Diagnostics Inc.
LUCDNASDAQHealthcare● Active
$0.99
+$0.03(+3.01%)
Market Cap$100964157
P/E Ratio—
52W High$1.629
52W Low$0.9
Lucid Diagnostics Inc. (LUCD) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LUCD · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($58.01M) | ($45.53M) | ($52.67M) | ($56.17M) | ($28.08M) |
| Depreciation & Amort. | $0.87M | $1.17M | $2.50M | $1.94M | $0.00M |
| Stock-Based Comp. | $4.49M | $4.53M | $6.82M | $14.99M | $9.60M |
| Change in Working Capital | ($2.81M) | ($4.43M) | $5.67M | $8.91M | $0.81M |
| Net Cash from Operations | ($46.48M) | ($44.14M) | ($32.82M) | ($29.68M) | ($17.67M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.20M) | ($0.65M) | ($0.22M) | ($0.91M) | ($0.86M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.20M) | ($0.65M) | ($0.22M) | ($4.11M) | ($0.86M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.36M | $18.00M | $10.00M | $0.00M | $0.00M |
| Net Cash from Financing | $59.03M | $48.25M | $29.46M | $2.61M | $72.08M |
| Free Cash Flow | |||||
| Free Cash Flow | ($46.48M) | ($44.79M) | ($33.04M) | ($30.59M) | ($18.53M) |
| FCF Margin %(computed) | -987.78% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Lucid Diagnostics Inc. data
About Lucid Diagnostics Inc. (LUCD) Cash Flow Statement
Lucid Diagnostics Inc. generated operating cash flow of ($0.05B) and free cash flow of ($0.05B) for 2025 — a FCF margin of -987.78%. Capital expenditure was ($0.00B).
Frequently asked questions
LUCD · 4 questionsLucid Diagnostics Inc. generated free cash flow of ($0.05B) for 2025, down 3.8% year-over-year.
LUCD free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10